7Baggers
The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.

ReShape Lifesciences, Inc.
(NASDAQ:RSLS) 

RSLS stock logo

ReShape Lifesciences Inc., a medical device company, provides products and services that manages and treat obesity and metabolic diseases in the United States, Australia, Europe, and internationally. The company's product portfolio includes Lap-Band System, a minimally invasive long-term treatment o...

Founded: 2002
Full Time Employees: 47
Sector: Healthcare
Industry: Medical Devices

Share this website to your friends
ReShape Lifesciences . Days Payable Outstanding ttm (DPO)
202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 028.1456.2784.41112.55140.69168.82196.96
ReShape Lifesciences . Days Receivable Outstanding ttm (DSO)
202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 011.7423.4835.2246.9658.770.4582.19
ReShape Lifesciences . Days Inventory Outstanding ttm (DIO)
202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 062.32124.64186.96249.29311.61373.93436.25
ReShape Lifesciences . Op Cashflow Per Share ttm
202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 -49.86-42.74-35.62-28.49-21.37-14.25-7.120
ReShape Lifesciences . Free Cashflow Per Share ttm
202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 -50.13-42.97-35.81-28.64-21.48-14.32-7.160
ReShape Lifesciences . Cash Per Share ttm
202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 01.953.895.847.789.7311.6813.62
ReShape Lifesciences . P/S ratio ttm
202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 00.10.190.290.380.480.570.67
ReShape Lifesciences . (GAAP) P/E ratio ttm
202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 -0.35-0.3-0.25-0.2-0.15-0.1-0.050
ReShape Lifesciences . P/B ratio ttm
202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 00.110.220.340.450.560.670.79
No extra charts and metrics for this ticker.